XML 22 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statement of Cash Flows Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows - operation activities:    
Net earnings $ 2,149 $ 2,477
Non-cash items -    
Share-based plans expense 47 45
Depreciation and amortization 521 501
Asset Impairment Charges 34 20
Customer financing valuation (benefit)/expense 249 (1)
Gain on dispositions, net (108) (4)
Other charges and credits, net 74 60
Changes in assets and liabilities -    
Accounts receivable 206 92
Unbilled receivables (183) (1,628)
Advances and progress billings 1,857 1,917
Inventories 2,725 (283)
Other current assets 164 (103)
Accounts payable 1,624 591
Accrued liabilities (919) (1,337)
Income taxes receivable, payable and deferred 116 348
Other long-term liabilities (281) (243)
Pension and other postretirement plans (188) (50)
Customer financing, net 152 44
Other (1) 124
Net cash provided by operating activities 2,788 3,136
Cash flows - investing activities:    
Payments to Acquire Property, Plant, and Equipment (501) (394)
Property, plant and equipment reductions 110 27
Acquisitions, net of cash acquired (276)
Contributions to investments (457) (249)
Proceeds from investments 366 752
Purchase of distribution rights (20)
Other (9) 3
Net cash provided/(used) by investing activities (767) 119
Cash flows - financing activities:    
New borrowings 5,237 2,687
Debt repayments (4,374) (1,371)
Contributions from noncontrolling interests 7 20
Stock options exercised 42 51
Employee taxes on certain share-based payment arrangements (233) (226)
Common shares repurchased (2,341) (3,000)
Dividends paid (1,161) (1,006)
Net cash used by financing activities (2,823) (2,845)
Effect of exchange rate changes on cash and cash equivalents, including restricted 1 8
Net (decrease) / increase in cash & cash equivalents, including restricted (801) 418
Cash & cash equivalents, including restricted, at beginning of year 7,813 8,887
Cash & cash equivalents, including restricted, at end of period 7,012 9,305
Restricted Cash and Cash Equivalents [1] (176) (70)
Cash and cash equivalents at end of period $ 6,836 $ 9,235
[1] Reflects amounts restricted in support of our workers’ compensation programs, employee benefit programs, and insurance premiums.